This website is only for B2B purposes, not for consumers.  

 

Reports 

 

The effect of 109 probiotic bacteria on gut health

 

The potential for probiotics in autism spectrum disorders

 

The use of probiotics in infections caused by E. coli 0104:H4

 

 

Probiotics  in general

 

Timmerman HM, Koning CJ, Mulder L, Rombouts FM, Beynen AC. Monostrain, multistrain and multispecies probiotics--A comparison of functionality and efficacy.Int J Food Microbiol. 2004 Nov 15;96(3):219-33. Review.

 

Heselmans M, Reid G, Akkermans LM, Savelkoul H, Timmerman H, Rombouts FM. Gut flora in health and disease: potential role of probiotics. Curr Issues Intest Microbiol. 2005 Mar;6(1):1-7.

 

Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low diversity of the gut mirobiota in infants with atopic eczema. J Allergy Clin Immunol. 2011.  

 

Mikselaar M, Lazar V, Onderdonk AB, Donelli G. Do probiotic preparations for humans really have efficacy? Microbial Ecology in Health and disease 2011 Nov 22. Review.

  

General publications on Ecologic® products

 

Reijnen K.  "Intestinal microbiota management on a scientific basis: Ecologic® probiotics" Innovations in Food Technology; 2009 February

 

 

Ecologic® AAD

 

Lang, FC. Use of a multi-species probiotics for the prevention of antibiotic associated diarrhea. Nutrafoods 2010;9(2); 27-31.


Koning CJM, Jonkers DMAE, Stobberingh EE, Mulder L, Rombouts FM and Stockbrügger RW. The Effect of a Multispecies Probiotic on the Intestinal Microbiota and Bowel Movements in Healthy Volunteers Taking the Antibiotic Amoxycillin. Am J Gastroenterol 2007;102:1–12

 

Hidding I, Koning C. Probiotics in the prevention and treatment of antibiotic associated diarrhoea. AgroFOOD 2005. 16(4): 18-20. 


Koning CJM. Probiotics during and after antibiotics, Designer probiotics are capable of more than reducing AAD. Nutracos 2011: 8-12. 

 

 

 

Ecologic® PANDA

Rutten et al. In vitro assessment of the immunomodulatory effects of multispecies probiotic formulations for management of allergic diseases. Beneficial Microbes 2011 Sep;2(3):183-192

 

Niers LE et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Clinical Journal of Allergy and Immunology. Allergy 2009 Sep;64(9):1349-58.   

 

Burks, E.  Probiotics in the prevention of atopic disease in children. AgroFOOD industry hi-tech, May/June 2007, Anno 18 - No. 3

 

Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF, Kapsenberg ML, Kimpen JL, Hoekstra MO. Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy. 2005 Nov;35(11):1481-9.

 

Niers LE, Hoekstra MO, Timmerman HM, van Uden NO, de Graaf PM, Smits HH, Kimpen JL, Rijkers GT.  Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells.

 

Niers LE, Rijkers GT, Timmerman HM, Knol EF, Hoekstra MO. Probiotics for cow's milk allergy: classification after intervention. J Allergy Clin Immunol. 2005 Feb;115(2):423; author reply 423-4.

Niers, Hoekstra, Timmerman, Rijkers "Designer probiotics for prevention of childhood asthma" Ernahrungsmedizin 2 - 2008.

 

Reijnen K, Nutraceuticals magazine. Prevention of allergy development. September 2009.

 

Van Hemert, Rijkers, Niers. Probiotics and the prevention of allergy. AgroFood 2010.

 

 

Ecologic® Relief

 

 


Bekkali N, Bongers MEJ, Van den Berg MM, Liem O, Benninga MA.The role of a probiotics mixture in the treatment of childhood constipation: a pilot study. Nutrition Journal 2007, 6:17

 

 

 

 Ecologic® Travel

 

Mulder L, Probiotics in the prevention of traveller's diarrhoea. Agrofood 2004 March/April: 43-44.

 

 

 

 Ecologic®  825

 

Mulder L. "Ecologic® 825 - A multispecies probiotic food supplement for IBD". NUTRAfoods 2008, 7(2/3)

Lutgendorff, F.Role of of mast cells and PPAR-gamma: Effects of probiotics on chronic stress-induced intestinal permeability in rats. Thesis of Femke Lutgendorff. 2009, Chapter 9. 241-271

 

Lutgendorff, F. Probiotics modulate mast cell degranulation and reduce stress-induced barrier dysfunction in vitro. Thesis of Femke Lutgendorff. 2009, Chapter 10, 274-307.


Ecologic® 641

 

Besslink et al. Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial. BMC Surgery. 2004;4(12).

 

Van Santvoort et al. Potentiële rol voor probiotica bij de preventie van infectieuze complicaties tijdens acute pancreatitis.Ned Tijdschr Geneeskd. 2006;150:535-40.

 

Ridwan et al. Antimicrobial activity of a multispecies probiotic (Ecologic641) against pathogens isolated from infected pancreatic necrosis. 2007;

 

Van Minnen et al., Modifcation of intestinal flora with multispecies probiotic reduces bacterial and improves clinical course in a rat model of acute pancreatitis. Surgery, 2007;141:470-80

 

Van Santvoort et al. Probiotics in surgery. Surgery 2008;143:1-7.

 

Lutgendorff et al. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Current Molecular Medicine. 2008;8.

  

Van Minnen et al. The use of animal models to study bacterial translocation during acute pancreatitis. J Gastrointest Surg. 2007;11:682–689.

 

Lutgendorff et al. Probiotics enhance glutathione biosynthesis and reduce oxidative stress in experimental acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2008; 295:1111-1121.

 

Besselink et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. 2008;371:651-659.

 

Besselink et al. Intestinal barrier dysfunction in a randomized trial in specific probiotic composition in acute pancreatitis. Annals of Surgery. 2009; 5 (250); 1-8.

 

Lutgendorff et al. Probiotics prevents intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. PLOS one. 2009;4(2).

 

 

 

Press releases Ecologic® products

Ecologic® Panda II: Development of Ecologic Panda II

 

Ecologic® Panda: PANDA study results published in the Journal of Allergy and Clinical Immunology.

 

Ecologic® FEMI: Approved by the Dutch notified body the KEMA as a medical device class IIa.

 

 

This website is only for B2B purposes, not for consumers.